Boston Scientific Corp financial data

Symbol
BSX on NYSE
Location
300 Boston Scientific Way, Marlborough, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % -12%
Quick Ratio 52.2 % +6.91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.48B shares +0.59%
Entity Public Float 113B USD +43.2%
Common Stock, Value, Issued 17M USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.48B shares +0.61%
Weighted Average Number of Shares Outstanding, Diluted 1.5B shares +0.55%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 19.4B USD +21.6%
Operating Income (Loss) 3.46B USD +37.9%
Nonoperating Income (Expense) -311M USD -9.12%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.27B USD +48.5%
Income Tax Expense (Benefit) 485M USD +17.2%
Earnings Per Share, Basic 1 USD/shares +53.7%
Earnings Per Share, Diluted 1 USD/shares +54.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.28B USD -49%
Inventory, Net 2.92B USD +6.1%
Other Assets, Current 701M USD +4.01%
Assets, Current 8.04B USD -8.29%
Deferred Income Tax Assets, Net 3.67B USD -3.85%
Property, Plant and Equipment, Net 3.8B USD +23.5%
Operating Lease, Right-of-Use Asset 495M USD +16.2%
Intangible Assets, Net (Excluding Goodwill) 7.16B USD +24.5%
Goodwill 18.2B USD +21.2%
Other Assets, Noncurrent 1.83B USD +11.6%
Assets 42.7B USD +12.2%
Accounts Payable, Current 1B USD +10.5%
Employee-related Liabilities, Current 1.31B USD +17.5%
Accrued Liabilities, Current 2.98B USD +21.2%
Liabilities, Current 5.33B USD -9.85%
Long-term Debt and Lease Obligation 11.1B USD +20.4%
Accrued Income Taxes, Noncurrent 403M USD +10.7%
Deferred Income Tax Liabilities, Net 242M USD +75.4%
Operating Lease, Liability, Noncurrent 445M USD +19.3%
Other Liabilities, Noncurrent 2.39B USD +29.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -689M USD -438%
Retained Earnings (Accumulated Deficit) 4.9B USD +133%
Stockholders' Equity Attributable to Parent 23.4B USD +13%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 23.6B USD +12.8%
Liabilities and Equity 42.7B USD +12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 541M USD +230%
Net Cash Provided by (Used in) Financing Activities 233M USD -85.2%
Net Cash Provided by (Used in) Investing Activities -500M USD -75.4%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 1.75B shares
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 314M USD -78.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.48B USD -44.3%
Deferred Tax Assets, Valuation Allowance 1.27B USD +3.93%
Deferred Tax Assets, Gross 4.99B USD -0.78%
Operating Lease, Liability 482M USD +3.43%
Depreciation 456M USD +15.7%
Payments to Acquire Property, Plant, and Equipment 187M USD +4.47%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.23B USD +53.9%
Lessee, Operating Lease, Liability, to be Paid 564M USD +4.64%
Property, Plant and Equipment, Gross 7.66B USD +14.4%
Operating Lease, Liability, Current 81M USD +6.58%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure -22.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 82M USD +10.8%
Deferred Tax Assets, Operating Loss Carryforwards 774M USD +4.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 529M USD +7.3%
Amortization of Intangible Assets 893M USD +6.44%
Depreciation, Depletion and Amortization 325M USD +6.91%
Deferred Tax Assets, Net of Valuation Allowance 3.72B USD -2.28%
Interest Expense 339M USD +17.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%